Human immunodeficiency virus infection: a survey with special emphasis on mucocutaneous manifestations
Friedman-Kien, A.E.; Farthing, C.
Seminars in Dermatology 9(2): 167-177
1990
ISSN/ISBN: 0278-145X PMID: 2202413 Document Number: 358655
Since the first reports of acquired immunodeficiency syndrome (AIDS) in 1981, many dermatological conditions have been reported to occur more commonly in people infected with human immunodeficiency virus (HIV). Acute HIV infection may first present as a skin eruption; the onset of immunosuppression after years of infection with HIV may be heralded by the development of various viral, fungal, bacterial, papulosquamous, or neoplastic eruptions. HIV disease often presents first to dermatologists who must be aware of subtle presentations and the possibility of underlying HIV infection--as well as alert to danger signals that indicate the need for urgent treatment or referral.
Document emailed within 1 workday
Related Documents
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94Brahim, J.S.; Roberts, M.W. 1990: Oral manifestations of human immunodeficiency virus infection Ear Nose and Throat Journal 69(7): 464; 467-469; 472-474
Fuller, C.; Clark, R.A.; Kissinger, P.; Abdalian, S.E. 1996: Clinical manifestations of infection with human immunodeficiency virus among adolescents in Louisiana Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 18(6): 422-428
Gilad, J.; Walfisch, A.; Borer, A.; Schlaeffer, F. 2003: Gender differences and sex-specific manifestations associated with human immunodeficiency virus infection in women European Journal of Obstetrics Gynecology and Reproductive Biology 109(2): 199-205
Purdy, B.D.; Plaisance, K.I. 1989: Infection with the human immunodeficiency virus: epidemiology, pathogenesis, transmission, diagnosis, and manifestations American Journal of Hospital Pharmacy 46(6): 1185-1209
Katz, R.L.; Alappattu, C.; Glass, J.P.; Bruner, J.M. 1989: Cerebrospinal fluid manifestations of the neurologic complications of human immunodeficiency virus infection Acta Cytologica 33(2): 233-244
Kordy, F.; Al-Hajjar, S.; Frayha, H.H.; Al-Khlaif, R.; Al-Shahrani, D.; Akthar, J. 2006: Human immunodeficiency virus infection in Saudi Arabian children: transmission, clinical manifestations and outcome Annals of Saudi Medicine 26(2): 92-99
Darney, P.D.; Myhra, W.; Atkinson, E.S.; Meier, J. 1989: Sero survey of human immunodeficiency virus infection in women at a family planning clinic: absence of infection in an indigent population in San Francisco American Journal of Public Health 79(7): 883-885
Melbye, M.; Njelesani, E.K.; Bayley, A.; Mukelabai, K.; Manuwele, J.K.; Bowa, F.J.; Clayden, S.A.; Levin, A.; Blattner, W.A.; Weiss, R.A. 1986: Evidence for heterosexual transmission and clinical manifestations of human immunodeficiency virus infection and related conditions in Lusaka, Zambia Lancet 2(8516): 1113-1115
Lado Lado, F.L.; Barrio Gómez, E.; Carballo Arceo, E.; Cabarcos Ortiz de Barrón, A. 2000: Tuberculosis and human immunodeficiency virus infection: clinical manifestations and performance of diagnostic procedures according to distinct forms of the localization of disease Anales de Medicina Interna 17(1): 13-18
Kreiss, J.K.; Castro, K.G. 1990: Special considerations for managing suspected human immunodeficiency virus infection and AIDS in patients from developing countries Journal of Infectious Diseases 162(4): 955-960
Ning, T.-l.; Guo, Y.; Liu, Z.-q.; Xia, J.-h.; Yu, M.-h.; Shen, S.; Xiao, Y.; Cheng, S.-H. 2011: Survey on recent infection of human immunodeficiency virus among men who have sex with men in Tianjin during 2008 - 2009 Zhonghua Liu Xing Bing Xue Za Zhi 32(11): 1087-1090
Anonymous 1988: 1988 agent summary statement for human immunodeficiency virus and report on laboratory-acquired infection with human immunodeficiency virus Morbidity and Mortality Weekly Report 37(S-4): 22
Lin, W.-C.; Lin, H.-H.; Lee, S.S.-J.; Sy, C.-L.; Wu, K.-S.; Chen, J.-K.; Tsai, H.-C.; Chen, Y.-S. 2016: Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country Journal of Microbiology Immunology and Infection 49(5): 729-736
Nicoll, A.; Hutchinson, E.; Soldan, K.; McGarrigle, C.; Parry, J.V.; Newham, J.; Mahoney, A.; Nicholas, S.; Heptonstall, J.; Gill, O.N. 1994: Survey of human immunodeficiency virus infection among pregnant women in England and Wales: 1990-93 Communicable Disease Report. Cdr Review 4(10): R115-R120
Kidangazhiayathmana, A. 2011: Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic Indian Journal of Dermatology Venereology and Leprology 77(6): 729
Diaz, A.; Ten, A.; Marcos, H.; Gutiérrez, G.; González-García, J.; Moreno, S.; Barrios, A.M.ía.; Arponen, S.; Portillo, Ál.; Serrano, R.; García, M.T.; Pérez, J.é L.; Toledo, J.; Royo, M.C.; González, G.; Izquierdo, A.; Viloria, L.J.; López, I.; Elizalde, L.áz.; Martínez, E.; Castrillejo, D.; Aranguren, R.; Redondo, C.; Diez, M. 2015: Factors determining irregular attendance to follow-up visits among human immunodeficiency virus patients: results of the hospital survey of patients infected with human immunodeficiency virus Enfermedades Infecciosas y Microbiologia Clinica 33(5): 324-330
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Dusheiko, G.M.; Brink, B.A.; Conradie, J.D.; Marimuthu, T.; Sher, R. 1989: Regional prevalence of hepatitis B, delta, and human immunodeficiency virus infection in southern Africa: a large population survey American Journal of Epidemiology 129(1): 138-145
Segat, L.; Crovella, S. 2012: HLA-G 14bp del/ins genetic variation: association with susceptibility to human immunodeficiency virus-1 vertical transmission but not with human immunodeficiency virus-1 infection through horizontal transmission Tissue Antigens 80(1): 12-13